
|Articles|November 1, 2003
Biotech Benefits Aid Anti-aging
Author(s)Caroline Helwick
Las Vegas - The next-generation of cosmeceuticals capitalize on discoveries gleaned from biotechnology research. These five new compounds appear to represent innovative approaches to anti-aging strategies, but by objective measures the jury is still out, according to Patricia Farris, M.D., of Metairie, Louisiana. Dr. Farris delivered a talk on new anti-aging agents at the Fall Clinical Dermatology Conference.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Phase 2 Nemolizumab Trial Opens for CPUO
4
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
5


















